You are here

Coronary Intervention & Surgery

 

A new cardiac imaging tool allows surgeons to repair serious residual holes in the heart that may occur when repairing a child’s heart defect.

In 2015, patients who underwent transcatheter aortic valve replacement (TAVR) had a decrease in in-hospital mortality and one-year mortality and an increase in 30-day post procedure pacemaker insertion, according to a registry analysis.

Cigarette smokers who were younger than 50 years old were more than eight times more likely to have an acute ST-segment elevation MI (STEMI) than non-smokers in their age category, according to an analysis of two studies in the United Kingdom.

A new metallic heart stent from Berlin, Germany-based Biotronik was proved effective in new research presented at VEITHsymposium 2016, a cardiology conference in New York.

Abbott Laboratories’ new Absorb bioresorbable heart stent has been approved in Japan to treat coronary artery disease, joining the U.S. and Canada in countries that have approved its use, according to a statement from Abbott.

 

Recent Headlines

Surgery within a year of drug-eluting stent implantation may increase risk of MI, cardiac death

Patients who underwent surgery within 12 months of receiving treatment with a drug-eluting stent by PCI had an increased risk of 30-day MI and cardiac death compared with those who did not receive a stent and did not have ischemic heart disease, according to a registry analysis in Denmark.

ACC releases updated findings from four cardiovascular registries

The American College of Cardiology (ACC) recently released detailed data from four registries that are part of the National Cardiovascular Data Registries (NCDR).

Johns Hopkins researchers find personalized treatment effective for ‘gray zone’ blood pressure patients

New research from Johns Hopkins found that by using heart CT scans, physicians could give patients with “gray zone” blood pressure—or slightly higher than normal blood pressure—personalized treatment.

Cardiovascular Research Foundation releases schedule for CTO Summit

The Cardiovascular Research Foundation announced that the Chronic Total Occlusion (CTO) Summit is taking place Feb. 23 and 24 at the New York Marriott Marquis.

Reducing cocaine use could reverse coronary artery disease caused by drug use

While cocaine use is associated with an increased risk of developing coronary artery disease, new research shows that the condition could be reversed if users reduce or stop taking the addictive drug.

ACC journal names noted interventional cardiologist as editor-in-chief

David J. Moliterno, MD, was named the editor-in-chief of the Journal of the American College of Cardiology: Cardiovascular Interventions on Jan. 11.

Children undergoing heart transplants could be at increased risk of developing kidney failure later in life

A new study examining thousands of people who’ve had heart transplants as children shows they have an increased risk of suffering from kidney failure later in life.

Big data shows how risk of heart disease impacts aging process

Researchers have identified 26 different predictive biomarker signatures to help determine how well a person is aging.

Ignorance a leading cause of hypertension in Canada

A study published in the American Journal of Hypertension found that 50 percent of the Canadian public is unaware that they suffer from high blood pressure. Furthermore, most are unwilling to address or manage their high blood pressure. 

ACC releases expert consensus decision pathway for TAVR patients

The American College of Cardiology (ACC) released an expert consensus decision pathway to provide a framework for physicians to manage adults with aortic stenosis who are undergoing transcatheter aortic valve replacement (TAVR).

Pages